Konferenzen  >  Medizin & Gesundheitswesen  >  Translationale Medizin, Klinische Studien  >  Indien

Virtue Insight

Clinical Trials Series 2025 emerges as a timely and essential platform to explore the future of clinical research and innovation. Bringing together leaders from across the clinical trials ecosystem—including sponsors, CROs, regulatory bodies, academic researchers, technology providers, and patient advocates—this summit offers a collaborative space to examine the latest developments, share strategic insights, and drive forward-thinking discussions.

Email: Kavitha@virtueinsight.co.in

clinical trials, clinical research, CROs, Clinical studies, drugs, regulatory, patients, clinical R&D, Medical Affairs, Regulatory Affairs, Quality control, pharma, pharmaceuticals

IIT (BHU), Varanasi

Drug Discovery and Translational Healthcare 2025 (DDTH 2025) will be held on December 2-3, 2025, at the School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, India, in collaboration with two prestigious societies, Bioinformatics and Drug Discovery Society (BDDS)" and "Biotechnology Society of India (BSI) ". This two-day event will feature keynote, plenary, and invited lectures by leading scientists and academics, alongside oral and poster presentations by students. The conference will focus on applied bioinformatics and various aspects of translational healthcare. DDTH 2025 aims to offer an exceptional platform for staying up-to-date with the latest research, fostering information exchange, and enabling networking opportunities among researchers. We warmly invite you to submit your posters and register for the conference.

Organizing Chairman/Secretaries;     Tel.: [0000000000];     Email: ddthiitbhuvaranasi@gmail.com

Computer Aided Drug Design/Structure-Based Drug Designing, Biotechnology and Healthcare, Omics and Bioinformatics for healthcare, Protein targets and therapeutic proteins